Literature DB >> 7717408

Variability of the genetic contribution of Quebec population founders associated to some deleterious genes.

E Heyer1, M Tremblay.   

Abstract

Relatively high frequencies of some rare inherited disorders can be found in the Saguenay Region (Quebec). To understand this phenomenon, a research project on the 17th-century founder effect that led to the formation of French Canadians' gene pool is being carried out. The focus of this study is on founders who contributed to the Saguenay gene pool and who are related to contemporary probands suffering from any one of five hereditary diseases: cystic fibrosis, tyrosinemia, hemochromatosis, Charlevoix-Saguenay spastic ataxia, and sensorimotor polyneuropathia with or without agenesis of the corpus callosum. A control group has been added for comparison purposes. Altogether, 545 ascending genealogies have been reconstructed, using the Interuniversity Institute for Population Research's RETRO database, leading to > 2,500 founders. The genetic contribution of each founder to each group has been measured. Results show that (1) nearly 80% of the individuals' gene pool come from founders who settled in Nouvelle-France in the 17th century, whatever the group; (2) 15% of the founders explain 90% of the total genetic contribution of the founders, but this pattern varies from one group to another; (3) there is no subgroup of founders more related to any given group of individuals.

Entities:  

Mesh:

Year:  1995        PMID: 7717408      PMCID: PMC1801195     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  5 in total

1.  Recursive descent probabilities for rare recessive lethals.

Authors:  E A Thompson; K Morgan
Journal:  Ann Hum Genet       Date:  1989-10       Impact factor: 1.670

2.  Genealogical analysis of cystic fibrosis families and chromosome 7q RFLP haplotypes in the Hutterite Brethren.

Authors:  T M Fujiwara; K Morgan; R H Schwartz; R A Doherty; S R Miller; K Klinger; P Stanislovitis; N Stuart; P C Watkins
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

3.  Cystic fibrosis mutations in North American populations of French ancestry: analysis of Quebec French-Canadian and Louisiana Acadian families.

Authors:  R Rozen; R H Schwartz; B C Hilman; P Stanislovitis; G T Horn; K Klinger; J Daigneault; M De Braekeleer; B Kerem; L Tsui
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

4.  A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.

Authors:  M Grompe; M St-Louis; S I Demers; M al-Dhalimy; B Leclerc; R M Tanguay
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

5.  Hereditary tyrosinemia type I: strong association with haplotype 6 in French Canadians permits simple carrier detection and prenatal diagnosis.

Authors:  S I Demers; D Phaneuf; R M Tanguay
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

  5 in total
  23 in total

1.  A case of Lenz microphthalmia syndrome.

Authors:  F F Ozkinay; C Ozkinay; H Yüksel; A Yenigun; G Sapmaz; O Aksu
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  Sequence analysis of the mitochondrial genomes from Dutch pedigrees with Leber hereditary optic neuropathy.

Authors:  Neil Howell; Roelof-Jan Oostra; Piet A Bolhuis; Liesbeth Spruijt; Lorne A Clarke; David A Mackey; Gwen Preston; Corinna Herrnstadt
Journal:  Am J Hum Genet       Date:  2003-05-06       Impact factor: 11.025

3.  Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension.

Authors:  P Hamet; E Merlo; O Seda; U Broeckel; J Tremblay; M Kaldunski; D Gaudet; G Bouchard; B Deslauriers; F Gagnon; G Antoniol; Z Pausová; M Labuda; M Jomphe; F Gossard; G Tremblay; R Kirova; P Tonellato; S N Orlov; J Pintos; J Platko; T J Hudson; J D Rioux; T A Kotchen; A W Cowley
Journal:  Am J Hum Genet       Date:  2005-03-30       Impact factor: 11.025

4.  The effect of the Neolithic expansion on European molecular diversity.

Authors:  Mathias Currat; Laurent Excoffier
Journal:  Proc Biol Sci       Date:  2005-04-07       Impact factor: 5.349

5.  Homozygosity haplotype allows a genomewide search for the autosomal segments shared among patients.

Authors:  Hitoshi Miyazawa; Masaaki Kato; Takuya Awata; Masakazu Kohda; Hiroyasu Iwasa; Nobuyuki Koyama; Tomoaki Tanaka; Shunei Kyo; Yasushi Okazaki; Koichi Hagiwara
Journal:  Am J Hum Genet       Date:  2007-05-02       Impact factor: 11.025

6.  Genetic predictors of depressive symptoms in cardiac patients.

Authors:  Jeanne M McCaffery; Qing Ling Duan; Nancy Frasure-Smith; Amina Barhdadi; Francois Lespérance; Pierre Théroux; Guy A Rouleau; Marie-Pierre Dubé
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

7.  Fine mapping of genome-wide association study signals to identify genetic markers of the plasma triglyceride response to an omega-3 fatty acid supplementation.

Authors:  Bastien Vallée Marcotte; Frédéric Guénard; Simone Lemieux; Patrick Couture; Iwona Rudkowska; Philip C Calder; Anne Marie Minihane; Marie-Claude Vohl
Journal:  Am J Clin Nutr       Date:  2019-01-01       Impact factor: 7.045

8.  Genealogical analysis as a new approach for the investigation of drug intolerance heritability.

Authors:  Marc Tremblay; Tarek Bouhali; Daniel Gaudet; Diane Brisson
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

9.  Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Authors:  P N Tonin; A M Mes-Masson; P A Futreal; K Morgan; M Mahon; W D Foulkes; D E Cole; D Provencher; P Ghadirian; S A Narod
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

10.  Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide.

Authors:  Laura M Fiori; Brigitte Wanner; Valérie Jomphe; Jordie Croteau; Frank Vitaro; Richard E Tremblay; Alexandre Bureau; Gustavo Turecki
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.